What is King Pharmaceuticals's all other lines — total IBNR?

King Pharmaceuticals (KG) reported all other lines — total IBNR of 551,000,000% in Q4 2025.

What does all other lines — total IBNR mean?

This represents the total Incurred But Not Reported (IBNR) reserves for the 'All other lines' segment. It serves as an actuarial estimate of the liability for claims that have occurred but have not yet been reported to the company, indicating the level of uncertainty in future claim payments.

King Pharmaceuticals KG All other lines — Total IBNR

Other product segments

General Liability

4,098,200,000%—

European Hospital Liability

1,391,000,000%—

Commercial Auto Liability

715,500,000%—

International

313,500,000%—

Similar metrics at other companies

AIGReserve for Incurred But Not Reported (IBNR) Claims

$334M-15.4%

CNACorporate & Other — Net IBNR Reserves

$238M-11.2%

PFGReserve for Incurred But Not Reported (IBNR) Claims

$950.4M+1.8%

BOWUnderwriting Division — IBNR

$210.79M+42.2%

CNAGeneral Liability — IBNR

341,000,000,000%+19,500,000,000pp

CNAOther Professional Liability and Management Liability — IBNR

268,900,000,000%+100,000,000pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's all other lines — total ibnr.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's all other lines — total IBNR?: King Pharmaceuticals (KG) reported all other lines — total IBNR of 551,000,000% in Q4 2025.
What does all other lines — total IBNR mean?: This represents the total Incurred But Not Reported (IBNR) reserves for the 'All other lines' segment. It serves as an actuarial estimate of the liability for claims that have occurred but have not yet been reported to the company, indicating the level of uncertainty in future claim payments.